ABC News and Press, AmerisourceBergen Corporation From 10/06/22

Summary After a few years of stagnation, shares of AmerisourceBergen have come to life again. AmerisourceBergen is seeing solid growth, leverage is low, and opioid settlements have been announced. Valuations look very fair here, albeit that higher interest rates have lowered v...

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2022 on Thursday, November 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the resu...

Biopharma Outlook Therapeutics ( NASDAQ: OTLK ) and U.S. drug distributor AmerisourceBergen ( NYSE: ABC ) on Tuesday said they had entered into a commercialization agreement for the anticipated launch of eye diseases treatment ONS-5010. The company in late Aug. res...

AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Lorence H. Kim, M.D., 48, as a new independent director, effective October 1, 2022. With the election of Dr. Kim, the Board of Directors will increase from ten to eleven members, nine of wh...

Summary McKesson has seen solid growth in recent years, with strong operating momentum seen in recent times, in part aided by the pandemic. This momentum and a good deal of opioid litigation uncertainties disappearing made that investors were upbeat on the future. Shares have ...

Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...

Summary Glenview Capital Management’s 13F portfolio value decreased from $4.94B to $4B this quarter. The number of positions decreased from 60 to 55. They increased Cigna, Aptiv plc, and Change Healthcare while dropping Bausch Health, Meritor, and AmerisourceBergen. The...

AmerisourceBergen ( NYSE: ABC ) on Monday said it would acquire PharmaLex Holding GmbH, a provider of specialized services for the life sciences industry, for €1.28B in cash. PharmaLex would be acquired from funds advised by AUCTUS Capital Partners AG and the deal w...

Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leadi...

The U.S. Department of Health and Human Services (HHS) on Tuesday said it had awarded a $19.8M contract to drug distributor AmerisourceBergen ( NYSE: ABC ) to expand and speed up the distribution of vaccines and treatments for monkeypox. The contract allows the Strategic N...